Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

Pilar Ruiz,1 Manuel Causse,2 Manuel Vaquero,1 Juan Bautista Gutierrez,1,2 Manuel Casal1,2 1Mycobacteria Reference Center, Department of Microbiology, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain; 2Microbiology Laboratory, Reina Sofía Univers...

Full description

Bibliographic Details
Main Authors:	Ruiz P, Causse M, Vaquero M, Gutierrez JB, Casal M
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-12-01
Series:	Infection and Drug Resistance
Subjects:	Abbott RealTime MTB RIF/INH Resistance assay M.tuberculosis Mutations.
Online Access:	https://www.dovepress.com/evaluation-of-a-new-automated-abbott-realtime-mtb-rifinh-assay-for-qua-peer-reviewed-article-IDR

Similar Items

Karakteristik Morfologi Mycobacterium tuberculosis yang Terpapar Obat Anti TB Isoniazid (INH) secara Morfologi
by: Widodo Widodo, et al.
Published: (2017-08-01)

Paradoxical results of two automated real-time PCR assays in the diagnosis of pleural tuberculosis
by: Soraya E. Morales-López, et al.
Published: (2017-01-01)

The Abbott RealTime MTB assay and the Cepheid GeneXpert assay show comparable performance for the detection of Mycobacterium tuberculosis in sputum specimens
by: Sheng Fen Wang, et al.
Published: (2016-04-01)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
by: Zheyuan Wu, et al.
Published: (2020-02-01)

Efficiency of Genexpert MTB/RIF in Patients with Newly Diagnosed and Recurrent Pulmonary Tuberculosis
by: Ye.N. Raznatovskaia, et al.
Published: (2015-04-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
by: Diriba K, et al.
Published: (2021-09-01)

Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01)

Evaluation of the geneXpert MTB/RIF assay for early diagnosis of tuberculosis and detection of rifampicin resistance in pulmonary and extrapulmonary specimens
by: Ali Albay, et al.
Published: (2016-09-01)

GeneXpert MTB/RIF and Mycobacterium tuberculosis Sputum Culture in Establishing the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance in Suspected Childhood Pulmonary Tuberculosis in Soetomo Hospital
by: Berlian Beatrix Rarome, et al.
Published: (2020-12-01)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
by: A. Andama, et al.
Published: (2021-01-01)

Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children
by: Ni Made Mertaniasih, et al.
Published: (2020-05-01)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

Utility of GeneXpert MTB/RIF assay for the diagnosis of pulmonary and extra-pulmonary tuberculosis, A report from Egypt
by: Enas, M. Hefzy, et al.
Published: (2021-02-01)

Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study
by: Wakjira Kebede, et al.
Published: (2020-08-01)

Usefulness of Xpert MTB/RIF Ultra to Rapidly Diagnose Sputum Smear-Negative Pulmonary Tuberculosis Using Bronchial Washing Fluid
by: Jung-Yien Chien, et al.
Published: (2020-09-01)

The limitations of the Cepheid GeneXpert® Mtb/Rif assay for the diagnosis and management of polyresistant pulmonary tuberculosis
by: Dahlia Hopmeier, et al.
Published: (2020-10-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda
by: Ngabonziza, J.C.S., et al.
Published: (2021)

Performance of Xpert MTB/RIF by Using Gastric Lavage Sample in The Diagnosis of Pulmonary Tuberculosis in HIV Patients with Suspected Pulmonary Tuberculosis
by: Manuel Lamberto Willem Mboeik, et al.
Published: (2018-03-01)

Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF
by: Marva Seifert, et al.
Published: (2021-08-01)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01)

A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
by: Xichao Ou, et al.
Published: (2015-02-01)

Performance of Xpert/MTB/RIF assay for childhood pulmonary tuberculosis among HIV negative children with real world evidence in China
by: Lu Xia, et al.
Published: (2020-11-01)

XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC
by: A. D. Adambekova, et al.
Published: (2014-01-01)

Assessment of diagnostic accuracy of Gene Xpert MTB/RIF in diagnosis of suspected retreatment pulmonary tuberculosis patients
by: Takwa E. Meawed, et al.
Published: (2016-07-01)

Incremental detection of pulmonary tuberculosis among presumptive patients by GeneXpert MTB/RIF® over fluorescent microscopy in Mwanza, Tanzania: an operational study
by: Jeremiah Seni, et al.
Published: (2015-06-01)

Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration
by: Mulualem Tadesse, et al.
Published: (2016-01-01)

Performance of Xpert® MTB/RIF in detecting Multidrug-Resistance Tuberculosis in West Java, Indonesia
by: Edhyana Sahiratmadja, et al.
Published: (2020-06-01)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
by: Nhu Nguyen Thi Quynh, et al.
Published: (2013-01-01)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
by: S. Atashi, et al.
Published: (2017-09-01)

Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020-01-01)

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
by: Ayinalem Alemu, et al.
Published: (2020-01-01)

Rolling out Xpert MTB/RIF® for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
by: Ishani Pathmanathan, et al.
Published: (2017-03-01)

CHARACTERISTICS AND EFFICIENCY OF TREATMENT IN TUBERCULOSIS PATIENTS DEPENDING ON THE ХPERT MTB/RIF RESULTS
by: A. M. MАLIK
Published: (2017-10-01)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
by: Suraj Kumar, et al.
Published: (2017-04-01)

Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens
by: Jinghui Du, et al.
Published: (2015-01-01)

Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis using tissue specimens
by: Zibo Zhou, et al.
Published: (2021-04-01)